GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BerGenBio ASA (OSL:BGBIO) » Definitions » Cyclically Adjusted PS Ratio

BerGenBio ASA (OSL:BGBIO) Cyclically Adjusted PS Ratio : 0.51 (As of May. 29, 2025)


View and export this data going back to 2017. Start your Free Trial

What is BerGenBio ASA Cyclically Adjusted PS Ratio?

As of today (2025-05-29), BerGenBio ASA's current share price is kr1.93. BerGenBio ASA's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec24 was kr3.80. BerGenBio ASA's Cyclically Adjusted PS Ratio for today is 0.51.

The historical rank and industry rank for BerGenBio ASA's Cyclically Adjusted PS Ratio or its related term are showing as below:

OSL:BGBIO' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.4   Med: 0.47   Max: 2.39
Current: 0.51

During the past 10 years, BerGenBio ASA's highest Cyclically Adjusted PS Ratio was 2.39. The lowest was 0.40. And the median was 0.47.

OSL:BGBIO's Cyclically Adjusted PS Ratio is ranked better than
90.95% of 497 companies
in the Biotechnology industry
Industry Median: 5.33 vs OSL:BGBIO: 0.51

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

BerGenBio ASA's adjusted revenue per share data of for the fiscal year that ended in Dec24 was kr0.024. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is kr3.80 for the trailing ten years ended in Dec24.

Shiller PE for Stocks: The True Measure of Stock Valuation


BerGenBio ASA Cyclically Adjusted PS Ratio Historical Data

The historical data trend for BerGenBio ASA's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BerGenBio ASA Cyclically Adjusted PS Ratio Chart

BerGenBio ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 2.15

BerGenBio ASA Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 2.15

Competitive Comparison of BerGenBio ASA's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, BerGenBio ASA's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BerGenBio ASA's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BerGenBio ASA's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where BerGenBio ASA's Cyclically Adjusted PS Ratio falls into.


;
;

BerGenBio ASA Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

BerGenBio ASA's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=1.93/3.80
=0.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BerGenBio ASA's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec24 is calculated as:

For example, BerGenBio ASA's adjusted Revenue per Share data for the fiscal year that ended in Dec24 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec24 (Change)*Current CPI (Dec24)
=0.024/134.8000*134.8000
=0.024

Current CPI (Dec24) = 134.8000.

BerGenBio ASA Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201512 0.000 100.900 0.000
201612 0.000 104.400 0.000
201712 0.000 106.100 0.000
201812 3.718 109.800 4.565
201912 13.244 111.300 16.040
202012 0.692 112.900 0.826
202112 0.760 118.900 0.862
202212 0.439 125.900 0.470
202312 0.000 131.900 0.000
202412 0.024 134.800 0.024

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


BerGenBio ASA  (OSL:BGBIO) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


BerGenBio ASA Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of BerGenBio ASA's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BerGenBio ASA Business Description

Industry
Traded in Other Exchanges
Address
Mollendalsbakken 9, Bergen, NOR, 5009
BerGenBio ASA is a clinical-stage biopharmaceutical Company focused on developing novel medicines for aggressive diseases. The company's clinical asset, bemcentinib, targeting the receptor tyrosine kinase AXL, is currently in development in a Ph1b/2a study in 1L STK 11 mutated NSCLC and preclinical development for severe respiratory infections.

BerGenBio ASA Headlines

No Headlines